NCT02609022 2019-01-28Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia GravisCuraVacPhase 1/2 Completed24 enrolled
NCT00619671 2013-01-16A Pilot Trial of Rituxan in Refractory Myasthenia GravisUniversity of VermontPhase 1/2 Completed10 enrolled